Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

Publication | Closed Access

DOI

154

Citations

References

2014

Year

Pedro Cahn, Jaime Andrade‐Villanueva, José Ramón Arribas, José M. Gatell, Javier R. Lama, Michael Norton, Patricia Patterson, Juan Sierra Madero, Omar Sued, María Inés Figueroa,

The Lancet Infectious Diseases

Open LabelHuman RetrovirusAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyVirologyPharmacotherapyDual TherapyHivAntiviral DrugMedicineNon-inferiority Gardel Trial